I have to agree that the announcement could have been better presented. The data should have been in tables and graphs with some colour and some more explanation for the average retail investor.
Having said that the results (while already flagged at the interim) were excellent and the market will do what the market does.
As the data builds the market will take more notice. We should lodge our EFS approval request with the FDA next quarter and breakthrough sometime after that.
Ann: Anti-Calcification Study, page-48
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
-0.300(1.73%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| $17.00 | $17.44 | $16.95 | $184.6K | 10.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |